OE MRI to Predict Treatment Response After TACE in HCC Patients

Enrolling by invitation · Not applicable

Conditions studied: HCC - Hepatocellular Carcinoma, TACE, SIRT

In brief

To predict response of HCC to TACE using dynamic oxygen-enhanced (dOE)-MRI for assessment of the level of tumor hypoxia before and after treatment.

Key facts

Study ID

NCT07617038

Run by

Université de Montréal

People needed

60

Starts

2024-11-27

Expected to finish

2029-12-20

Last updated by the study team

2026-06-01

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• no pulmonary disease
• able to stay 2 hours in MRI

You may not qualify if…

• contraindication for MRI
• contraindication for contrast injection
• claustrophobia

Where it is running

• CRCHUM — Montreal, Quebec, Canada

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.